Skip to content
Pharmaceuticals
ONP-002
Technology & Pipeline
Pipeline
Science & Technology
News & Media
News & Media
Publications
Investors
Why Invest
About
Overview
Management Team
Board of Directors
Scientific Advisors
Contact Us
Navigation Menu
Navigation Menu
Pharmaceuticals
ONP-002
Technology & Pipeline
Pipeline
Science & Technology
News & Media
News & Media
Publications
Investors
Why Invest
About
Overview
Management Team
Board of Directors
Scientific Advisors
Contact Us
Contact Us
Investor Relations
📧
ir@oragenics.com
📞 1-813-286-7900
🏛 NYSE American:
OGEN
Access Investor Portal
Media Relations
📧
media@oragenics.com
📞 1-813-286-7900
General Inquiries
Please enable JavaScript in your browser to complete this form.
Please enable JavaScript in your browser to complete this form.
Name Type Email
Name
*
First
Last
Email
*
Inquiry Type
*
Investor Inquiry
Media Inquiry
Clinical
Partnership
General
Message
Send Message
Stock Information
Exchange
NYSE American
Ticker Symbol
OGEN
SEC Filings
View on EDGAR
View Investor Presentation
Read Latest News